The Australia physiotherapy market is expected to witness growth from $638 Mn in 2022 to $1,126 Mn in 2030 with a CAGR of 7.35% for the year 2022-2030. Arthritis, osteoporosis and back pain are the major conditions that require physiotherapy. The market is segmented by treatments and conditions.
The APAC Autoimmune Hemolytic Anemia (AIHA) market is expected to grow as a result of the increased prevalence of AIHA in the APAC region. The market is segmented by disease type, therapy type, drugs, and by route of administration. AstraZeneca and Roche are some of the key players in the APAC AIHA market.
China Paroxysmal Nocturnal Hemoglobinuria (PNH) therapeutics market is growing due to the increased cases of PNH cases in China. Although being a rare disease, its prevalence in China and the increased adoption of novel therapeutics to treat PNH are the major market drivers of the China PNH therapeutics market.
Patient Support Programs (PSP) in Australia provide patients with significant value through the accessibility of information and support during and after the course of their treatment, therefore, leading to the growth of Australia patient support programs. Pharmaceutical companies sponsored PSPs are designed to aid compliance and lifestyle choices.
The demand for physiotherapy services keeps increasing due to the rising geriatric population and musculoskeletal disorders and injuries thereby providing more opportunities for the Singapore physiotherapy market to grow. The physiotherapy market is segmented by treatment and conditions.
Kenya sleep management market is witnessing significant growth due to factors like busy lifestyles leading to disturbance in sleeping patterns and depression in Kenya. The introduction of home sleep test kits and wearables increases the opportunities for market growth.
The India oncology drugs market is expected to grow from $3.57 Bn in 2022 to 10.62 Bn in 2030 with a CAGR of 14.6% for the year 2022-2030. The rising prevalence of different types of cancers and new drug launches are responsible for this significant growth rate of India oncology drugs market.
UK physiotherapy market is at around $1.38 Bn in 2022 and is expected to grow to $1.87 Bn in 2030 with a CAGR of 3.85% for the year 2022-2030. The increasing geriatric population and high prevalence of musculoskeletal disorders are the major market drivers of UK physiotherapy market. The UK physiotherapy market is segmented by treatment and conditions.
The Egypt Over The Counter (OTC) Market is a rapidly growing industry, driven by factors such as increased access to healthcare, growing awareness of self-care, and a rising middle class with higher disposable incomes. The market is dominated by multinational companies, with a number of local companies also participating in the market.
The Egypt Osteoporosis Market is expected to grow due to the increasing aging population and increasing awareness of osteoporosis. Osteoporosis is a condition characterized by low bone density and increased risk of fractures, which is common in older adults. The market is segmented by drug class and by route of administration.
The Egypt gastrointestinal market is growing due to a number of factors, including increasing prevalence of gastrointestinal diseases, rising awareness about digestive health, and advancements in medical technology. The government has taken steps to improve healthcare infrastructure, including increasing investment in hospitals and clinics, which is driving growth in the gastrointestinal market. The market is dominated by multinational pharmaceutical companies, but there is also a growing number of local players.
The Egypt Dental Care Market is expected to grow as a result of the increasing prevalence of dental disorders and the rising demand for cosmetic dentistry in Egypt. The Egypt dental care market is segmented by products and equipment, services, and the end user. Egypt is expected to offer high-growth opportunities to the players during the forecast period. SHOFU Dental and KaVo Dental are some of the key players in the Egypt dental care market.